At Healthfieldtips.com you’ll find women healthy living guides and trusted nutritional advice.
The U.S. Food and Drug Administration (FDA) has approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to Perjeta (pertuzumab) for patients with HER2-positive breast cancer. This approval represents a significant…
